ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04810	Regulation of actin cytoskeleton	2/2	264/7206	0.00133730796856
ko04015	Rap1 signaling pathway	2/2	278/7206	0.00148318840632
ko04014	Ras signaling pathway	2/2	279/7206	0.00149389734788
ko04010	MAPK signaling pathway	2/2	321/7206	0.00197845769287
ko05200	Pathways in cancer	2/2	492/7206	0.00465284250175
ko04011	MAPK signaling pathway - yeast	1/2	53/7206	0.0146568814678
ko05130	Pathogenic Escherichia coli infection	1/2	77/7206	0.0212583661201
ko04370	VEGF signaling pathway	1/2	77/7206	0.0212583661201
ko05131	Shigellosis	1/2	82/7206	0.022630882623
ko05212	Pancreatic cancer	1/2	83/7206	0.0229052703599
ko05218	Melanoma	1/2	85/7206	0.0234539302686
ko05120	Epithelial cell signaling in Helicobacter pylori infection	1/2	92/7206	0.0253730265261
ko05211	Renal cell carcinoma	1/2	96/7206	0.026468805489
ko05132	Salmonella infection	1/2	98/7206	0.0270164638421
ko05100	Bacterial invasion of epithelial cells	1/2	99/7206	0.0272902352371
ko04520	Adherens junction	1/2	103/7206	0.0283849356011
ko04666	Fc gamma R-mediated phagocytosis	1/2	122/7206	0.0335763454117
ko04912	GnRH signaling pathway	1/2	122/7206	0.0335763454117
ko04660	T cell receptor signaling pathway	1/2	124/7206	0.0341220006542
ko04933	AGE-RAGE signaling pathway in diabetic complications	1/2	135/7206	0.0371203502055
ko04670	Leukocyte transendothelial migration	1/2	151/7206	0.0414732653006
ko04722	Neurotrophin signaling pathway	1/2	160/7206	0.0439174463882
ko05224	Breast cancer	1/2	174/7206	0.0477133039156
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/2	182/7206	0.0498789754781